These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30133562)

  • 1. Improving adenoviral vectors and strategies for prostate cancer gene therapy.
    Tamura RE; de Luna IV; Lana MG; Strauss BE
    Clinics (Sao Paulo); 2018 Aug; 73(suppl 1):e476s. PubMed ID: 30133562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.
    Tamura RE; da Silva Soares RB; Costanzi-Strauss E; Strauss BE
    Cancer Biol Ther; 2016 Dec; 17(12):1221-1230. PubMed ID: 27646031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Oxidants Distinguishes Susceptibility of Prostate Carcinoma Cell Lines to p53 Gene Transfer Mediated by an Improved Adenoviral Vector.
    Tamura RE; Hunger A; Fernandes DC; Laurindo FR; Costanzi-Strauss E; Strauss BE
    Hum Gene Ther; 2017 Aug; 28(8):639-653. PubMed ID: 28181816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.
    Sauthoff H; Pipiya T; Heitner S; Chen S; Norman RG; Rom WN; Hay JG
    Hum Gene Ther; 2002 Oct; 13(15):1859-71. PubMed ID: 12396618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 Gene therapy for lung cancer.
    Swisher SG; Roth JA
    Curr Oncol Rep; 2002 Jul; 4(4):334-40. PubMed ID: 12044243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL; Gurnani M; Syed J; Dell J; Hartman B; Cartwright M; Johnson RC
    Hum Gene Ther; 1998 Mar; 9(5):681-94. PubMed ID: 9551616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, INGN 101, p53 gene therapy--Introgen, RPR/INGN 201.
    BioDrugs; 2003; 17(3):216-22. PubMed ID: 12749760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stromal Cells for Linked Delivery of Oncolytic and Apoptotic Adenoviruses to Non-small-cell Lung Cancers.
    Hoyos V; Del Bufalo F; Yagyu S; Ando M; Dotti G; Suzuki M; Bouchier-Hayes L; Alemany R; Brenner MK
    Mol Ther; 2015 Sep; 23(9):1497-506. PubMed ID: 26084970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bivariate analysis of the p53 pathway to evaluate Ad-p53 gene therapy efficacy.
    Jacobberger JW; Sramkoski RM; Zhang D; Zumstein LA; Doerksen LD; Merritt JA; Wright SA; Shults KE
    Cytometry; 1999 Oct; 38(5):201-13. PubMed ID: 10516606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aloperine in combination with therapeutic adenoviral vector synergistically suppressed the growth of non-small cell lung cancer.
    Muhammad T; Sakhawat A; Khan AA; Huang H; Khan HR; Huang Y; Wang J
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):861-874. PubMed ID: 32088783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines.
    Lee SE; Jin RJ; Lee SG; Yoon SJ; Park MS; Heo DS; Choi H
    Anticancer Res; 2000; 20(1A):417-22. PubMed ID: 10769689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate-specific expression of the diphtheria toxin A chain (DT-A): studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer.
    Li Y; McCadden J; Ferrer F; Kruszewski M; Carducci M; Simons J; Rodriguez R
    Cancer Res; 2002 May; 62(9):2576-82. PubMed ID: 11980652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent anti-tumor activity of telomerase-dependent and HSV-TK armed oncolytic adenovirus for non-small cell lung cancer in vitro and in vivo.
    Zhang JF; Wei F; Wang HP; Li HM; Qiu W; Ren PK; Chen XF; Huang Q
    J Exp Clin Cancer Res; 2010 May; 29(1):52. PubMed ID: 20487549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer.
    Muhammad T; Sakhawat A; Khan AA; Ma L; Gjerset RA; Huang Y
    Stem Cell Res Ther; 2019 Jun; 10(1):190. PubMed ID: 31238944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study.
    Schuler M; Herrmann R; De Greve JL; Stewart AK; Gatzemeier U; Stewart DJ; Laufman L; Gralla R; Kuball J; Buhl R; Heussel CP; Kommoss F; Perruchoud AP; Shepherd FA; Fritz MA; Horowitz JA; Huber C; Rochlitz C
    J Clin Oncol; 2001 Mar; 19(6):1750-8. PubMed ID: 11251006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy.
    Jin F; Xie Z; Kuo CJ; Chung LW; Hsieh CL
    Cancer Gene Ther; 2005 Mar; 12(3):257-67. PubMed ID: 15565180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of gene therapy for prostate cancer using a novel promoter of prostate-specific antigen.
    Dannull J; Belldegrun AS
    Br J Urol; 1997 Mar; 79 Suppl 1():97-103. PubMed ID: 9088281
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteonectin Promoter-Mediated Suicide Gene Therapy of Prostate Cancer.
    Hsiao WC; Sung SY; Chung LWK; Hsieh CL
    Methods Mol Biol; 2019; 1895():27-42. PubMed ID: 30539527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.